LifeVantage's shares surged 11% on the successful GLP-1 weight-management trial, but caution is advised until a long-term trend is confirmed. Concerns include product pricing, retention rates, and MLM ...
MarketBeat on MSN
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...
Telehealth company Hims & Hers Health Inc. HIMS was already a thriving platform discretely selling doctor-prescribed sexual health treatment along with prescription hair loss and mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results